Strategic Investment Solutions’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Sell
6,623
-142
-2% -$7.21K 0.07% 124
2026
Q1
$361K Sell
6,765
-61
-0.9% -$3.58K 0.09% 113
2025
Q4
$424K Sell
6,826
-3
-0% -$185 0.1% 96
2025
Q3
$410K Buy
6,829
+326
+5% +$19.9K 0.11% 101
2025
Q2
$407K Buy
6,503
+67
+1% +$4.03K 0.12% 91
2025
Q1
$387K Sell
6,436
-830
-11% -$51.6K 0.11% 75
2024
Q4
$424K Sell
7,266
-1,029
-12% -$61.2K 0.14% 75
2024
Q3
$491K Buy
+8,295
New +$474K 0.15% 71
2023
Q4
$446K Sell
8,257
-396,849
-98% -$19.4M 0.08% 115
2023
Q3
$21.4M Buy
405,106
+399,907
+7,692% +$21.3M 0.26% 62
2023
Q2
$278K Sell
5,199
-2,682
-34% -$148K 0.06% 109
2023
Q1
$425K Buy
7,881
+1,755
+29% +$93.4K 0.08% 115
2022
Q4
$343K Buy
+6,126
New +$311K 0.17% 65

Other funds holding IHI

Strategic Investment Solutions's IHI Position: Q2 2026 in Review

Strategic Investment Solutions reduced its iShares US Medical Devices ETF (IHI) stake by 2.1% in Q2 2026, selling an estimated $7.21K and leaving 6,623 shares worth $327K. The position accounts for 0.07% of the portfolio, ranked #124.

Strategic Investment Solutions first reported a position in IHI in Q4 2022 and has held it in 13 quarters since. The position peaked at $21.4M in Q3 2023. 65 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Strategic Investment Solutions held 6,623 shares of iShares US Medical Devices ETF worth $327K as of Q2 2026.
  • Strategic Investment Solutions sold 142 iShares US Medical Devices ETF shares in Q2 2026, an estimated $7.21K.
  • iShares US Medical Devices ETF made up 0.07% of Strategic Investment Solutions's portfolio in Q2 2026, its #124 holding.
  • Strategic Investment Solutions first reported a position in iShares US Medical Devices ETF in Q4 2022 and has held it in 13 quarters since.
  • Strategic Investment Solutions's iShares US Medical Devices ETF position peaked at $21.4M in Q3 2023.
  • 65 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.